The latest price target for Iridex (NASDAQ:IRIX) was reported by Stifel on May 15, 2024. The analyst firm set a price target for $2.00 expecting IRIX to rise to within 12 months (a possible 14.95% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Iridex (NASDAQ:IRIX) was provided by Stifel, and Iridex maintained their hold rating.

There is no last upgrade for Iridex

The last downgrade for IRIDEX Corp happened on August 26, 2022 when Stifel changed their price target from $5 to $3 for IRIDEX Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Iridex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Iridex was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.

While ratings are subjective and will change, the latest Iridex (IRIX) rating was a maintained with a price target of $2.00 to $2.00. The current price Iridex (IRIX) is trading at is $1.74, which is out of the analyst’s predicted range.